US Patent Issued to Thoeris on Sept. 16 for "Use of glutamine synthetase for treating fatty liver disease" (Austrian Inventor)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,986, issued on Sept. 16, was assigned to Thoeris GmbH (Vienna).

"Use of glutamine synthetase for treating fatty liver disease" was invented by Tamara Nicolson (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the treatment of fatty liver disease, by administration of glutamine synthetase."

The patent was filed on Sept. 28, 2019, under Application No. 17/281,240.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12414986&OS=12414986&RS=12414986 ...